Pharma The CEO and CFO of SkylineDx talk about the company’s latest product, the MMprofiler™, a prognostic test to determine the level of risk of a multiple myeloma. Also discussed are SkylineDx’s future plans and how private funding capital is fostering a renaissance of the Dutch biotech sector. Personalized medicine will improve…
See our Cookie Privacy Policy Here
